Author:
Rabie Helena,Frigati Lisa Jane
Subject
Virology,Infectious Diseases,Immunology,Epidemiology
Reference9 articles.
1. Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study;Cahn;Lancet,2013
2. Dolutegravir-based antiretroviral therapy for patients coinfected with tuberculosis and human immunodeficiency virus: a multicenter, noncomparative, open-label, randomized trial;Dooley;Clin Infect Dis,2020
3. Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list;Penazzato;Lancet HIV,2019
4. Bollen PDJ, Moore CL, Mujuru HA, et al. Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial. Lancet HIV; 7: e533–44.
5. Development of antiretroviral resistance in children with HIV in low-and middle-income countries;Fitzgerald;J Infect Dis,2013
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献